Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Harvard Business School
Moodys
Johnson and Johnson
AstraZeneca

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR VOLTAREN-XR

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Voltaren-xr

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00171691 Safety of Diclofenac Sodium Gel in Knee Osteoarthritis Completed Novartis Phase 3 2004-10-01 This study will test the efficacy and safety of topical Voltaren in the treatment of knee osteoarthritis.
NCT00276419 Treatment of Breast Pain Using A Medication (Diclofenac) Applied to the Skin Terminated Mayo Clinic Phase 2/Phase 3 2005-06-01 The study was a randomized, double-blinded, crossover trial of topical diclofenac and placebo (10 weeks of each) for the treatment of noncyclic breast pain.
NCT00310908 Comparison Between Tramadol Hcl and Other Analgesics in the Treatment of Renal Colic Completed Grumental Phase 4 2006-09-01 The purpose of this study is to determine whether Tramadol Hcl is as effective as Voltaren a non-steroidal antiinflammatory drug, and Dipyrone in amelioration of the pain caused by acute renal colic.
NCT00310908 Comparison Between Tramadol Hcl and Other Analgesics in the Treatment of Renal Colic Completed Hadassah Medical Organization Phase 4 2006-09-01 The purpose of this study is to determine whether Tramadol Hcl is as effective as Voltaren a non-steroidal antiinflammatory drug, and Dipyrone in amelioration of the pain caused by acute renal colic.
NCT00523120 Topical Voltaren in Otitis Externa Terminated Sieff Medical Center Phase 2 2008-09-01 Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia.
NCT00715091 Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis Completed Charite University, Berlin, Germany Phase 4 2008-09-01 This is a randomised, controlled, multi-centre clinical trial on AS patients. Experimental intervention: continuous (daily) treatment with diclofenac cholestyramine 150 mg (Voltaren Resinate), divided into 75mg Voltaren twice dailyControl intervention: treatment on-demand (as needed) with diclofenac-cholestyramine 75 to 150 mg (Voltaren Resinate). The treatment strategy of the control intervention (on-demand) reflects current clinical practice in AS. Duration of intervention per patient: 2 years Follow-up per patient: safety assessment 3 months after termination of the trial.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Voltaren-xr

Condition Name

Condition Name for Voltaren-xr
Intervention Trials
Pain 10
Osteoarthritis 3
Temporomandibular Joint Dysfunction Syndrome 2
Osteoarthritis, Knee 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Voltaren-xr
Intervention Trials
Osteoarthritis 7
Osteoarthritis, Knee 6
Calculi 2
Infertility 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Voltaren-xr

Trials by Country

Trials by Country for Voltaren-xr
Location Trials
United States 40
India 13
Germany 6
Egypt 5
Poland 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Voltaren-xr
Location Trials
California 3
Texas 3
Louisiana 2
Florida 2
Arizona 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Voltaren-xr

Clinical Trial Phase

Clinical Trial Phase for Voltaren-xr
Clinical Trial Phase Trials
Phase 4 12
Phase 3 13
Phase 2/Phase 3 2
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Voltaren-xr
Clinical Trial Phase Trials
Completed 20
Recruiting 12
Not yet recruiting 4
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Voltaren-xr

Sponsor Name

Sponsor Name for Voltaren-xr
Sponsor Trials
Cairo University 4
Assiut University 2
GlaxoSmithKline 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Voltaren-xr
Sponsor Trials
Other 32
Industry 25
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Baxter
Johnson and Johnson
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.